LifePoint Health, Inc. (LPNT) Downgraded by BidaskClub

BidaskClub downgraded shares of LifePoint Health, Inc. (NASDAQ:LPNT) from a hold rating to a sell rating in a research report sent to investors on Tuesday, August 1st.

Other equities analysts have also issued reports about the stock. Zacks Investment Research lowered shares of LifePoint Health from a buy rating to a hold rating in a research report on Tuesday, July 11th. Royal Bank Of Canada restated a buy rating and set a $77.00 target price on shares of LifePoint Health in a research report on Wednesday, July 5th. Leerink Swann upgraded shares of LifePoint Health from a market perform rating to an outperform rating and raised their target price for the stock from $73.00 to $74.00 in a research report on Tuesday, June 6th. Morgan Stanley assumed coverage on shares of LifePoint Health in a research report on Tuesday, June 6th. They set an equal weight rating and a $65.00 target price on the stock. Finally, Barclays PLC raised their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the stock an equal weight rating in a research report on Monday, May 1st. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of $66.18.

Shares of LifePoint Health (NASDAQ:LPNT) opened at 57.45 on Tuesday. The stock has a market cap of $2.30 billion, a P/E ratio of 12.86 and a beta of 0.86. The firm’s 50-day moving average is $61.96 and its 200 day moving average is $62.71. LifePoint Health has a 52-week low of $50.60 and a 52-week high of $70.95.

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.06. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The company’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period last year, the firm posted $0.69 earnings per share. Analysts forecast that LifePoint Health will post $4.07 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.com-unik.info/2017/08/19/lifepoint-health-inc-lpnt-downgraded-by-bidaskclub-to-sell-updated-updated.html.

In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares in the company, valued at approximately $32,365,920.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman William F. Carpenter III sold 17,653 shares of the business’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now owns 439,841 shares in the company, valued at $28,616,055.46. The disclosure for this sale can be found here. 7.28% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of LPNT. BlackRock Inc. raised its stake in shares of LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after buying an additional 3,714,004 shares during the last quarter. LSV Asset Management increased its position in LifePoint Health by 83.5% in the second quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock valued at $133,934,000 after buying an additional 907,469 shares during the period. Point72 Asset Management L.P. increased its position in LifePoint Health by 291.1% in the first quarter. Point72 Asset Management L.P. now owns 688,352 shares of the company’s stock valued at $45,087,000 after buying an additional 512,352 shares during the period. Victory Capital Management Inc. increased its position in LifePoint Health by 130.6% in the second quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock valued at $54,804,000 after buying an additional 462,211 shares during the period. Finally, Norges Bank purchased a new position in LifePoint Health during the fourth quarter valued at about $19,865,000. Institutional investors own 99.59% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit